Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79.5M
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
28.6M
-
Shares change
-
-801K
-
Total reported value, excl. options
-
$202M
-
Value change
-
-$3.58M
-
Put/Call ratio
-
0.46
-
Number of buys
-
60
-
Number of sells
-
-50
-
Price
-
$7.02
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q2 2016
141 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q2 2016.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.6M shares
of 79.5M outstanding shares and own 35.95% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (4.6M shares), VANGUARD GROUP INC (2.33M shares), Camber Capital Management LLC (1.5M shares), FRONTIER CAPITAL MANAGEMENT CO LLC (1.43M shares), TOCQUEVILLE ASSET MANAGEMENT L.P. (1.4M shares), PICTET ASSET MANAGEMENT LTD (1.33M shares), BlackRock Fund Advisors (1.3M shares), BB BIOTECH AG (1.18M shares), FMR LLC (1.14M shares), and BlackRock Institutional Trust Company, N.A. (813K shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.